vantage health (VNTH) Key Developments
Vantage Health Deleted From OTCBB
Jul 9 14
Vantage Health’s common stock has been deleted from OTC Bulletin Board effective July 9, 2014 on account of its ineligibility for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11.
Vantage Health Inc. announced delayed 10-Q filing
Feb 14 14
On 02/14/2014, Vantage Health Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Vantage Health and Scripps Translational Science Institute Form Strategic Partnership for Mobile Health Technology
Feb 10 14
Vantage Health Inc. and its parent company Nanobeak Inc. announced that they have formed a strategic partnership with Scripps Translational Science Institute (STSI) for the advancement of mobile health technology. Vantage Health is developing personalized and point-of-care screening using Apps based upon chemical sensing residing within a small device attached to a smartphone. STSI's Center for Digital Medicine is committed to helping in the development and research of novel mobile health devices to accelerate their uptake into clinical practice. Through this strategic partnership, STSI will assist in the testing, evaluation and detection of certain basic Volatile Organic Compounds (VOCs) using Gas Chromatography and Mass Spectrometry to calibrate the results of the Vantage sensor through validation. STSI will also assist in the testing, evaluation and detection of certain VOC's commonly associated with Lung Cancer, using Gas Chromatography and Mass Spectrometry to calibrate the results of the Vantage sensor through validation. STSI and Vantage Health will collaborate in the planning and execution of clinical trials. The actual clinical trials are expected to be carried out at STSI, as well as a 2nd location in the Midwest and a 3rd location in New England.
Vantage Health Inc Appoints William S. Rees, Jr. as Independent Member of the Board of Directors
Dec 18 13
Vantage Health Inc. announced the appointment of Dr. William S. Rees, Jr., as the first independent member of the Board of Directors of Vantage Health, Inc. Dr. William S. Rees, Jr. served 2006 - 2009 as the Deputy Under Secretary of Defense for Laboratories and Basic Sciences, and presently is the Managing Director of efkairia, LLC.
Vantage Health, Inc. Announces Board Changes
Nov 8 13
Vantage Health, Inc. announced that effective November 7, 2013, all members of board of directors, with the exception of Lisa Ramakrishnan, resigned from all positions as a director or officer of the company. At such time, Ms. Ramakrishnan resigned from all positions as an officer of the company only, but remains as a director. Effective November 7, 2013, Mr. Barbera was appointed as a director of the company, such that the board of directors of the company consists of Mr. Barbera and Ms. Ramakrishnan. Mr. Barbera was also appointed to the offices of Chief Executive Officer, Chief Financial Officer, President and Treasurer of the company at such time. Effective January 1, 2014, Ms. Ramakrishnan will resign as a director of the company.